CRISPR Therapeutics AG Overview
CRISPR Therapeutics AG Target Price
Analysts' 12-month price predictions for CRSP.
Share Price
$54.06
Average Target Price
$52.00
3.8% downside
3.8% downside1 analysts in the last 4 months
High: $52 | Low: $52
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-05-09 | Robert W. BairdJack Allen | $52 | 3.8% downside |  |
| 2022-11-23 | Citigroup | $63 |  16.5% upside | |
| 2022-08-09 | Chardan CapitalGeulah Livshits | $79.3 | 46.7% upside | |
| 2022-06-17 | BMO CapitalKostas Biliouris | $98 | 81.3% upside | |
| 2022-04-28 | Credit Suisse | $78 | 44.3% upside | |
| 2022-02-16 | NeedhamGil Blum | $170 | 214.5% upside | |
| 2022-02-15 | Leerink PartnersRick Bienkowski | $120 | 122% upside | |
| 2022-01-07 | Wells FargoYanan Zhu | $105 | 94.2% upside | |
| 2021-11-04 | OppenheimerJay Olson | $172 | 218.2% upside | |
| 2021-10-12 | Piper SandlerEdward Tenthoff | $180 | 233% upside | |
| 2021-08-16 | Canaccord GenuityArlinda Lee | $160 | 196% upside | |
| 2021-06-11 | Roth CapitalAnthony Butler | $171 | 216.3% upside | |
| 2021-04-21 | JefferiesMaury Raycroft | $172 | 218.2% upside | |